NOUVEAU TRAITEMENT DE L'ENTEROCOLITE CHRONIQUE
- 专利权人:
- ABLYNX N.V.;ACTOGENIX NV
- 发明人:
- ROTTIERS, PIETER,VANDENBROUCKE, KLAAS
- 申请号：
- CA2619748
- 公开号：
- CA2619748C
- 申请日:
- 2006.08.30
- 申请国别(地区):
- CA
- 年份:
- 2016
- 代理人:
- 摘要：
- The present invention relates to a novel treatment of chronic enterocolitis.More specifically, the invention relates to the production of a medicamentcomprising anti-TNFalpha antibody producing lactic acid bacteria, and the useof this medicament in the treatment of chronic enterocolitis.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- ANTI-TNF ALPHA PRODUCING LACTIC ACID BACTERIA FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
- Anti-TNF alpha producing lactic acid bacteria for the treatment of chronic enterocolitis
- NOUVEAU TRAITEMENT DE L'ENTEROCOLITE CHRONIQUE
- Anti-TNF alpha producing lactic acid bacteria for the treatment of chronic enterocolitis
- Link Protein that binds to tumor necrosis factor alpha (TNF alpha)； Nucleic Acid Coding； vector； host Cell； production method； Pharmaceutical composition that comprises； its use to treat a disorder associated with TNF alpha； and a method for determining the presence of TNF -. In a sample.
